本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Summit Therapeutics PLC

25.08
+0.96003.98%
成交量:199.26萬
成交額:4,890.92萬
市值:185.01億
市盈率:-80.90
高:25.21
開:24.34
低:23.42
收:24.12
資料載入中...
2019/12/26

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/23

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/17

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/10

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/12/06

非美公司披露報告

[Amend] Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/06

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/11

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/11

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/19

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/18

SEC問詢函

[Cover]Correspondence
2019/06/18

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/12

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/14

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/01

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/27

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/02/13

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/01/22

非美公司披露報告

General statement of acquisition of beneficial ownership
2019/01/18

非美公司披露報告

Notice of Exempt Offering of Securities, item 06b
2019/01/14

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/01/11

超過5%披露

[Amend] General statement of acquisition of beneficial ownership